Encephabol (Pyritinol) 50 tablets 100 mg

Encephabol (Pyritinol) 50 tablets 100 mg

To favorites
Encephabol (Pyritinol) metabolic, nootropic effect, improves blood circulation in the ischemic areas of the brain, increases their oxygen supply, improves memory performance and restores disturbed metabolic processes in the nervous tissue
Active substance:Pyritinol
Pharmacological group:Nootropic
Dosage mg:100
Ordered on demand

Instructions for Encephabol (Pyritinol) 50 tablets 100 mg


Minimum age from. 1 year
Method of use Oral
Pack quantity 50 pcs
Minimum storage temperature allowed, °C 2 °C
Maximum storage temperature allowed, °C 25 °C
Storage Conditions In a sunproof room
Release form Pill
Country of manufacture Austria
Active substance Pyritinol
Scope Neurology
Pharmacological group N06BX02 Pyritinol
Registered as Medicinal agent

Release form
tab, envelope, 100 mg: 50 pcs


Tablets covered with a yellow shell, shiny; round, double-convex; two layers are visible on the cross section.

1 tab.
Pyritinol dihydrochloride monohydrate 100 mg

Auxiliary substances:
sodium carmellose - 1.6 mg,
magnesium stearate - 3.2 mg,
silicon dioxide colloidal - 4.8 mg,
sodium carboxymethyl starch - 6.4 mg,
lactose monohydrate - 19.8 mg,
cellulose powder - 24.2 mg.

Shell Composition:
the dye quinoline yellow 70% - 30 μg,
mountain glycolic wax - 80 μg,
gelatin - 800 μg,
acacia gum - 1.7 mg,
wheat flour - 8.2 mg,
titanium dioxide - 9 mg,
kaolin - 14.2 mg,
talc - 14.3 mg,
sucrose - 121.69 mg.

10 pcs - blister packs (5) - cardboard packs.

ATC codes
N06BX02 Pyritinol

Clinical-pharmacological groups / Group affiliation
Nootropic preparation

Active substance
Pyritinol dihydrochloride monohydrate

Pharmacotherapy group

Nootropic agent

Storage Conditions:

The drug Encephabol should be stored in a place inaccessible to children at a temperature of 15-25 °C.

Best before date
Shelf life is 5 years.

Testimony Encephabol:

Symptomatic treatment of impaired brain function, with concomitant dementia,
namely degenerative dementia, dementia of vascular genesis or mixed forms of degenerative and vascular dementia in the presence of the following major syndromes:
a breakdown of memory, concentration, and thought;
other vascular syndromes of the brain in cerebrovascular diseases.
Supportive therapy for the effects of traumatic brain injury in the presence of the following main symptoms:
a violation of consciousness;
attention and concentration disturbance;
brain dysfunction.
Disorders of mental development in children and adolescents.

Method of use, course and dosage:

Adults: In 2 tablets 3 times/day (600 mg of Pyritinol dihydrochloride monohydrate per day).
Children from 7 years: 1 tablet 1-3 times/day (100 to 300 mg of Pyritinol dihydrochloride monohydrate per day, depending on indications).

The drug Encephabol should be taken during or after meals. For sleep disorders, the last daily dose should not be taken in the evening or at night.
The duration of treatment depends on the clinical picture of the disease. As a rule, therapeutic success is achieved after 3-4 weeks of treatment. The optimal effect usually occurs in 6-12 weeks. Treatment should be at least 8 weeks long and may be continued if necessary.
After 3 months, check for indications for further treatment.

Application for kidney disorders
The drug Encephabol is contraindicated in kidney diseases in the anamnesis.

Use in liver disorders
The preparation is contraindicated in cases of pronounced liver dysfunctions.

Terms of Sale
The drug Encephabol is prescription.

Nosology (ICD codes)
Vascular dementia
Dementia unspecified
Personality and behavioural disorders caused by disease, damage or brain dysfunction
Mental retardation unspecified
Specific disorders of speech and language development
Specific learning disabilities
General disorders of psychological development
Developmental disorder
Cerebral atherosclerosis
Effects of cerebrovascular disease
Intracranial injury
Effects of head injuries

Pharmacological effect:

Nootropic drug Encephabol.
Increases pathologically reduced metabolism in the tissues of the brain, which is due to increased glucose capture and utilization, increases the metabolism of nucleic acids and the release of acetylcholine in the synapses of nerve cells, improves cholinergic transmission in the nervous tissue. Pyritinol helps stabilize the structure of cell membranes of neurons and their function by inhibiting lysosomal enzymes, thesis preventing the formation of free radicals

Active substance
Pharmacological group
Dosage mg
Pills in 1 package
Country of origin
Expiration Date
No reviews yet — your comment may be first.
All reviews 0
general rating
Also buying with this item
In stock
Vermox (Mebendazole) 6 tablets 100 mg
In stock
Eleflox (levofloxacin) 500 mg 10 tablets
In stock
Clindamycin 150 mg 16 capsules
In stock
Nolicin (Norfloxacin)
In stock